Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Acute Baclofen in Methadone-maintained Opioid Dependence
NCT05161351Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of baclofen in opioid use disorder (OUD) (2 arms), sponsored by Imperial College London. Primary endpoint: Number of Participants With Dose Limiting Toxicities at 24 hours. Started Jul 2021; status: completed.
02
Drugs
baclofen
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05161351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05161351.